Good afternoon and welcome to The Oncology Institute's Third Quarter 2024 Earnings Conference Call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A. At this ...
O’Reilly, M.D., Gastrointestinal Medical Oncologist at Memorial Sloan Kettering Cancer ... Provide updated RFS and OS data in an oral presentation at the 2024 ESMO Immuno-Oncology Congress, taking ...
Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback